Jing Zhang

Jing Zhang

Auto-generated profile, based on publicly available information

Jing Zhang

Department of Pathology, the First Hospital of Hebei Medical University, Hebei, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
XXXuqin Xie
Xuqin Xie
CFChuanwen Fan
Chuanwen Fan
BLBin Luo
Bin Luo
JZJing Zhang
Jing Zhang
LJLasse Jensen
Lasse Jensen
XSXiao-Feng Sun
Xiao-Feng Sun
P53 mutation is common and highly related to radiotherapy resistance in rectal cancer. APR-246, as a small molecule, can restore the tumor-suppressor function to mutant p53. As there is currently no existing study on combining APR-246 with radiation in rectal cancer, our objective was to investigate whether APR-246 could enhance the sensitivity of colorectal cancer cells, regardless of their p53 status, to radiation treatment. The combination treatment had synergistic effects on HCT116p53-R248W/− (p53Mut) cells, followed by HCT116p53+/+ [wild-type p53 (p53WT)] cells, and exhibited an additive effect on HCT116p53−/− (p53Null) cells through inhibiting proliferation, enhancing reactive oxygen species, and apoptosis. The results were confirmed in zebrafish xenografts. Mechanistically, p53Mut and p53WT cells shared more activated pathways and differentially expressed genes following the combination treatment, compared with p53Null cells, although the combination treatment regulated individual pathways in the different cell lines. APR-246 mediated radiosensitization effects through p53-dependent and -independent ways. The results may provide evidence for a clinical trial of the combination in patients with rectal cancer.

1 August 2023
Verified
Other
Open access
XXXuqin Xie
Xuqin Xie
CFChuanwen Fan
Chuanwen Fan
BLBin Luo
Bin Luo
JZJing Zhang
Jing Zhang
LJLasse Jensen
Lasse Jensen
XSXiao-Feng Sun
Xiao-Feng Sun
P53 mutation is common and highly related to radiotherapy resistance in rectal cancer. APR-246, as a small molecule, can restore the tumor-suppressor function to mutant p53. As there is currently no existing study on combining APR-246 with radiation in rectal cancer, our objective was to investigate whether APR-246 could enhance the sensitivity of colorectal cancer cells, regardless of their p53 status, to radiation treatment. The combination treatment had synergistic effects on HCT116p53-R248W/− (p53Mut) cells, followed by HCT116p53+/+ [wild-type p53 (p53WT)] cells, and exhibited an additive effect on HCT116p53−/− (p53Null) cells through inhibiting proliferation, enhancing reactive oxygen species, and apoptosis. The results were confirmed in zebrafish xenografts. Mechanistically, p53Mut and p53WT cells shared more activated pathways and differentially expressed genes following the combination treatment, compared with p53Null cells, although the combination treatment regulated individual pathways in the different cell lines. APR-246 mediated radiosensitization effects through p53-dependent and -independent ways. The results may provide evidence for a clinical trial of the combination in patients with rectal cancer.

27 November 2025
Verified
Other
Open access
XXXuqin Xie
Xuqin Xie
CFChuanwen Fan
Chuanwen Fan
BLBin Luo
Bin Luo
JZJing Zhang
Jing Zhang
LJLasse Jensen
Lasse Jensen
XSXiao-Feng Sun
Xiao-Feng Sun
Supplementary Data from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy


27 November 2025
Verified
Other
Open access
XXXuqin Xie
Xuqin Xie
CFChuanwen Fan
Chuanwen Fan
BLBin Luo
Bin Luo
JZJing Zhang
Jing Zhang
LJLasse Jensen
Lasse Jensen
XSXiao-Feng Sun
Xiao-Feng Sun
Figure S3 from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy

27 November 2025
Verified
Other
Open access
XXXuqin Xie
Xuqin Xie
CFChuanwen Fan
Chuanwen Fan
BLBin Luo
Bin Luo
JZJing Zhang
Jing Zhang
LJLasse Jensen
Lasse Jensen
XSXiao-Feng Sun
Xiao-Feng Sun
Figure S10 from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy